Evolent Health (EVH) PT Raised to $7 at Truist Securities
Tweet
Share
E-mailGet Alerts EVH Hot Sheet
Price: $4.81 +7.37%
Rating Summary:
21 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 24
Rating Summary:
21 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 24
Join SI Premium – FREE
Truist Securities analyst Jailendra Singh raised the price target on Evolent Health (NYSE: EVH) to $7.00 (from $6.00) while maintaining a Buy rating.
You May Also Be Interested In
- Natera (NTRA) PT Raised to $270 at BTIG
- Constellation Brands (STZ) PT Lowered to $157 at Jefferies
- Southwest (LUV) PT Raised to $61 at UBS Ahead of Q2 Print
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
